DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Weber JS, Gibney G, Sullivan RJ. et al.
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.
Lancet Oncol 2016;
17: 943-955
We do not assume any responsibility for the contents of the web pages of other providers.